Birth Control and Pregnancy Management in Pulmonary Hypertension

Karen M. Olsson; Xavier Jais

doi:10.1055/s-0033-1355438

Seminars in Respiratory and Critical Care Medicine, Inhaltsverzeichnis

Semin Respir Crit Care Med 2013; 34(05): 681-688
DOI: 10.1055/s-0033-1355438

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Birth Control and Pregnancy Management in Pulmonary Hypertension

Karen M. Olsson

¹Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany

,

Xavier Jais

²INSERM U999 (Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique), Centre Chirurgical Marie-Lannelongue, Le PlessisRobinson, France

› Institutsangaben

Abstract

Pregnancies in patients with pulmonary arterial hypertension (PAH) are associated with serious complications and mortality rates of more than 50%. Advanced medical therapies for PAH have been developed during the past years resulting in improved hemodynamics, exercise capacity, quality of life, and outcome. However, despite these advances, pregnancy in women with PAH is still associated with excessive maternal mortality. Consequently, all current guidelines strongly discourage pregnancy and recommend an effective method of contraception in women of childbearing age. If this fails, early pregnancy termination is advised. Those patients who choose to continue pregnancy should be treated with targeted PAH therapies including prostacyclin analogues and/or phosphodiesterase type 5 inhibitors. The care of the pregnant women with PAH requires a planned, multidisciplinary approach, preferably in a dedicated pulmonary hypertension referral center, focusing on close monitoring before, during and after delivery.

Keywords

hypertension - pulmonary - pregnancy - right heart failure

Volltext

Referenzen

References
1 Olschewski H, Gomberg-Maitland M. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 2008; 31: 801-901
2 Wilkins MR, Wharton J, Grimminger F, Ghofrani HA. Phosphodiesterase inhibitors for the treatment of pulmonary hypertension. Eur Respir J 2008; 32 (1) 198-209
3 Dupuis J, Hoeper MM. Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 2008; 31 (2) 407-415
4 Humbert M, Sitbon O, Chaouat A , et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173 (9) 1023-1030
5 Rich S, Dantzker DR, Ayres SM , et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107 (2) 216-223
6 Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998; 31 (7) 1650-1657
7 Galiè N, Hoeper MM, Humbert M , et al; Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC) European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34 (6) 1219-1263
8 McLaughlin VV, Archer SL, Badesch DB , et al; ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009; 119 (16) 2250-2294
9 Jaïs X, Olsson KM, Barbera JA , et al. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J 2012; 40 (4) 881-885
10 Bédard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?. Eur Heart J 2009; 30 (3) 256-265
11 Thorne S, Nelson-Piercy C, MacGregor A , et al. Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam Plann Reprod Health Care 2006; 32 (2) 75-81
12 Kerin JF, Cooper JM, Price T , et al. Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study. Hum Reprod 2003; 18 (6) 1223-1230
13 Hendrix NW, Chauhan SP, Morrison JC. Sterilization and its consequences. Obstet Gynecol Surv 1999; 54 (12) 766-777
14 Weiss BM, Hess OM. Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. Eur Heart J 2000; 21 (2) 104-115
15 Satoh H, Masuda Y, Izuta S, Yaku H, Obara H. Pregnant patient with primary pulmonary hypertension: general anesthesia and extracorporeal membrane oxygenation support for termination of pregnancy. Anesthesiology 2002; 97 (6) 1638-1640
16 Stout K. Pregnancy in women with congenital heart disease: the importance of evaluation and counselling. Heart 2005; 91 (6) 713-714
17 Bonnin M, Mercier FJ, Sitbon O , et al. Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005; 102 (6) 1133-1137 , discussion 5A–6A
18 Kiely DG, Condliffe R, Webster V , et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. BJOG 2010; 117 (5) 565-574
19 Gleicher N, Midwall J, Hochberger D, Jaffin H. Eisenmenger's syndrome and pregnancy. Obstet Gynecol Surv 1979; 34 (10) 721-741
20 Ma L, Liu W, Huang Y. Perioperative management for parturients with pulmonary hypertension: experience with 30 consecutive cases. Front Med 2012; 6 (3) 307-310
21 Katsuragi S, Yamanaka K, Neki R , et al. Maternal outcome in pregnancy complicated with pulmonary arterial hypertension. Circ J 2012; 76 (9) 2249-2254
22 Kametas NA, McAuliffe F, Hancock J, Chambers J, Nicolaides KH. Maternal left ventricular mass and diastolic function during pregnancy. Ultrasound Obstet Gynecol 2001; 18 (5) 460-466
23 Hytten F. Blood volume changes in normal pregnancy. Clin Haematol 1985; 14 (3) 601-612
24 Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C , et al; European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM); ESC Committee for Practice Guidelines. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011; 32 (24) 3147-3197
25 Ueland K. Maternal cardiovascular dynamics. VII. Intrapartum blood volume changes. Am J Obstet Gynecol 1976; 126 (6) 671-677
26 Pritchard JA. Changes in the Blood Volume during Pregnancy and Delivery. Anesthesiology 1965; 26: 393-399
27 Lund CJ, Donovan JC. Blood volume during pregnancy. Significance of plasma and red cell volumes. Am J Obstet Gynecol 1967; 98 (3) 394-403
28 Zwicke D. PAH and pregnancy: physiologic changes, challenges, and outcomes. Advances in Pulmonary Hypertension 2011; 10 (3) 173-177
29 Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003; 29 (2) 125-130
30 Hsu CH, Gomberg-Maitland M, Glassner C, Chen JH. The management of pregnancy and pregnancy-related medical conditions in pulmonary arterial hypertension patients. Int J Clin Pract Suppl 2011; 65 (172) 6-14
31 Cilberto CF, Marx GF, Johnston D. Physiological changes associated with pregnancy. Update in Anaesthesia 1998; 2: 1-3
32 Metcalfe J, Ueland K. Maternal cardiovascular adjustments to pregnancy. Prog Cardiovasc Dis 1974; 16 (4) 363-374
33 Uebing A, Steer PJ, Yentis SM, Gatzoulis MA. Pregnancy and congenital heart disease. BMJ 2006; 332 (7538) 401-406
34 Sugishita Y, Ito I, Kubo T. Pregnancy in cardiac patients: possible influence of volume overload by pregnancy on pulmonary circulation. Jpn Circ J 1986; 50 (4) 376-383
35 Wylie BJ, Epps KC, Gaddipati S, Waksmonski CA. Correlation of transthoracic echocardiography and right heart catheterization in pregnancy. J Perinat Med 2007; 35 (6) 497-502
36 Belfort MA, Rokey R, Saade GR, Moise Jr KJ. Rapid echocardiographic assessment of left and right heart hemodynamics in critically ill obstetric patients. Am J Obstet Gynecol 1994; 171 (4) 884-892
37 Penning S, Robinson KD, Major CA, Garite TJ. A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension. Am J Obstet Gynecol 2001; 184 (7) 1568-1570
38 Roberts NV, Keast PJ. Pulmonary hypertension and pregnancy—a lethal combination. Anaesth Intensive Care 1990; 18 (3) 366-374
39 Madden BP. Pulmonary hypertension and pregnancy. Int J Obstet Anesth 2009; 18 (2) 156-164
40 Huang S, DeSantis ER. Treatment of pulmonary arterial hypertension in pregnancy. Am J Health Syst Pharm 2007; 64 (18) 1922-1926
41 Monnery L, Nanson J, Charlton G. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Br J Anaesth 2001; 87 (2) 295-298
42 Stewart R, Tuazon D, Olson G, Duarte AG. Pregnancy and primary pulmonary hypertension : successful outcome with epoprostenol therapy. Chest 2001; 119 (3) 973-975
43 Price LC, Forrest P, Sodhi V , et al. Use of vasopressin after caesarean section in idiopathic pulmonary arterial hypertension. Br J Anaesth 2007; 99 (4) 552-555
44 Lam GK, Stafford RE, Thorp J, Moise Jr KJ, Cairns BA. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy. Obstet Gynecol 2001; 98 (5 Pt 2) 895-898
45 Wong PS, Constantinides S, Kanellopoulos V, Kennedy CR, Watson D, Shiu MF. Primary pulmonary hypertension in pregnancy. J R Soc Med 2001; 94 (10) 523-525
46 Bendayan D, Hod M, Oron G , et al. Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol 2005; 106 (5 Pt 2) 1206-1210
47 Elliot CA, Stewart P, Webster VJ , et al. The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J 2005; 26 (1) 168-173
48 Avdalovic M, Sandrock C, Hoso A, Allen R, Albertson TE. Epoprostenol in pregnant patients with secondary pulmonary hypertension: two case reports and a review of the literature. Treat Respir Med 2004; 3 (1) 29-34
49 Bildirici I, Shumway JB. Intravenous and inhaled epoprostenol for primary pulmonary hypertension during pregnancy and delivery. Obstet Gynecol 2004; 103 (5 Pt 2) 1102-1105
50 Geohas C, McLaughlin VV. Successful management of pregnancy in a patient with eisenmenger syndrome with epoprostenol. Chest 2003; 124 (3) 1170-1173
51 Lacassie HJ, Germain AM, Valdés G, Fernández MS, Allamand F, López H. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol 2004; 103 (5 Pt 2) 1118-1120
52 Molelekwa V, Akhter P, McKenna P, Bowen M, Walsh K. Eisenmenger's syndrome in a 27. week pregnancy—management with bosentan and sildenafil. Ir Med J 2005; 98 (3) 87-88
53 Badalian SS, Silverman RK, Aubry RH, Longo J. Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report. J Reprod Med 2000; 45 (2) 149-152
54 Mojoli F, Zanierato M, Campana C, Braschi A. Inhaled nitric oxide test in a pregnant patient with severe pulmonary hypertension. Anaesthesia 2006; 61 (9) 912
55 Takeuchi T, Nishii O, Okamura T, Yaginuma T. Primary pulmonary hypertension in pregnancy. Int J Gynaecol Obstet 1988; 26 (1) 145-150
56 Robinson JN, Banerjee R, Landzberg MJ, Thiet MP. Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension. Am J Obstet Gynecol 1999; 180 (4) 1045-1046
57 Sitbon O, Humbert M, Jaïs X , et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005; 111 (23) 3105-3111
58 Chamaidi A, Gatzoulis MA. Heart disease and pregnancy. Hellenic J Cardiol 2006; 47 (5) 275-291
59 Easterling TR, Ralph DD, Schmucker BC. Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. Obstet Gynecol 1999; 93 (4) 494-498
60 Magee LA, Schick B, Donnenfeld AE , et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996; 174 (3) 823-828
61 McMillan E, Martin WL, Waugh J , et al. Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome. Lupus 2002; 11 (6) 392-398
62 Cotrim C, Simões O, Loureiro MJ , et al. Acute resynchronization with inhaled iloprost in a pregnant woman with idiopathic pulmonary artery hypertension. Rev Port Cardiol 2006; 25 (5) 529-533
63 Coceani F, Kelsey L. Endothelin-1 release from lamb ductus arteriosus: relevance to postnatal closure of the vessel. Can J Physiol Pharmacol 1991; 69 (2) 218-221
64 Song YB, Park SW, Kim JH , et al. Outcomes of pregnancy in women with congenital heart disease: a single center experience in Korea. J Korean Med Sci 2008; 23 (5) 808-813
65 Siu SC, Sermer M, Colman JM , et al; Cardiac Disease in Pregnancy (CARPREG) Investigators. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001; 104 (5) 515-521
66 O'Hare R, McLoughlin C, Milligan K, McNamee D, Sidhu H. Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension. Br J Anaesth 1998; 81 (5) 790-792
67 Weiss BM, Maggiorini M, Jenni R , et al. Pregnant patient with primary pulmonary hypertension: inhaled pulmonary vasodilators and epidural anesthesia for cesarean delivery. Anesthesiology 2000; 92 (4) 1191-1194
68 Olofsson C, Bremme K, Forssell G, Ohqvist G. Cesarean section under epidural ropivacaine 0.75% in a parturient with severe pulmonary hypertension. Acta Anaesthesiol Scand 2001; 45 (2) 258-260
69 Ghai B, Mohan V, Khetarpal M, Malhotra N. Epidural anesthesia for cesarean section in a patient with Eisenmenger's syndrome. Int J Obstet Anesth 2002; 11 (1) 44-47
70 Chakravarty EF, Khanna D, Chung L. Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease. Obstet Gynecol 2008; 111 (4) 927-934
71 Power KJ, Avery AF. Extradural analgesia in the intrapartum management of a patient with pulmonary hypertension. Br J Anaesth 1989; 63 (1) 116-120
72 Blaise G, Langleben D, Hubert B. Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology 2003; 99 (6) 1415-1432
73 Smedstad KG, Cramb R, Morison DH. Pulmonary hypertension and pregnancy: a series of eight cases. Can J Anaesth 1994; 41 (6) 502-512
74 Barash PG, Nardi D, Hammond G , et al. Catheter-induced pulmonary artery perforation. Mechanisms, management, and modifications. J Thorac Cardiovasc Surg 1981; 82 (1) 5-12
75 George RB, Olufolabi AJ, Muir HA. Critical arrhythmia associated with pulmonary artery catheterization in a parturient with severe pulmonary hypertension. Can J Anaesth 2007; 54 (6) 486-487
76 Chou WR, Kuo PH, Shih JC, Yang PC. A 31-year-old pregnant woman with progressive exertional dyspnea and differential cyanosis. Chest 2004; 126 (2) 638-641
77 Martin JT, Tautz TJ, Antognini JF. Safety of regional anesthesia in Eisenmenger's syndrome. Reg Anesth Pain Med 2002; 27 (5) 509-513
78 Spinnato JA, Kraynack BJ, Cooper MW. Eisenmenger's syndrome in pregnancy: epidural anesthesia for elective cesarean section. N Engl J Med 1981; 304 (20) 1215-1217
79 Rosenberg B, Simon K, Peretz BA, Roguin N, Birkhahn HJ. [Eisenmenger's syndrome in pregnancy. Controlled segmental epidural block for cesarean section]. Reg Anaesth 1984; 7 (4) 131-133
80 Cole PJ, Cross MH, Dresner M. Incremental spinal anaesthesia for elective Caesarean section in a patient with Eisenmenger's syndrome. Br J Anaesth 2001; 86 (5) 723-726
81 Tibaldi G, Marchi L, Huscher M, Forlini G. [Anesthesia for cesarean section in a pregnant woman with Eisenmenger's syndrome. Description of a clinical case]. Minerva Ginecol 1988; 40 (2) 145-146
82 Lust KM, Boots RJ, Dooris M, Wilson J. Management of labor in Eisenmenger syndrome with inhaled nitric oxide. Am J Obstet Gynecol 1999; 181 (2) 419-423
83 Budev MM, Arroliga AC, Emery S. Exacerbation of underlying pulmonary disease in pregnancy. Crit Care Med 2005; 33 (10, Suppl): S313-S318
84 Hoeper MM, Granton J. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med 2011; 184 (10) 1114-1124
85 Kerbaul F, Rondelet B, Motte S , et al. Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2004; 32 (4) 1035-1040
86 Pagnamenta A, Fesler P, Vandinivit A, Brimioulle S, Naeije R. Pulmonary vascular effects of dobutamine in experimental pulmonary hypertension. Crit Care Med 2003; 31 (4) 1140-1146
87 Braun EB, Palin CA, Hogue CW. Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol. Anesth Analg 2004; 99 (1) 36-37
88 Tayama E, Ueda T, Shojima T , et al. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact Cardiovasc Thorac Surg 2007; 6 (6) 715-719